Modern genomic medicine is increasingly based on collaboration rather than isolation. Not every hospital or laboratory needs to build and maintain advanced genomic infrastructure internally. Accredited referral laboratories allow healthcare institutions to extend their diagnostic capabilities while retaining full ownership of patient care, clinical decision-making and long-term follow-up.
Hospitals and laboratories don’t always need to build a complete genomics department to deliver advanced genetic diagnostics.
Sometimes, what they need is an experienced clinical genomics partner that integrates seamlessly into existing diagnostic workflows, providing accredited testing, clinical interpretation, and access to advanced genomic technologies that would otherwise be difficult to implement in-house.
Breda Genetics physicians and scientists work as an extension of your clinical team, supporting individual referrals, urgent cases and long-term genomic programs with the same commitment to diagnostic quality.
Modern genomic medicine is increasingly built on collaboration rather than isolation. As genomic testing becomes more sophisticated, laboratories and hospitals increasingly rely on specialised partners to address complex diagnostic and interpretative challenges.
In this context, outsourcing is more than the transfer of laboratory work. It allows hospital teams to focus their internal resources on patient care, research and innovation, while providing access to advanced genomic expertise. In many settings, it also represents a more sustainable and cost-effective model than developing and maintaining the entire infrastructure in-house.
In time-critical clinical situations, speed is measured by the entire diagnostic pathway rather than by sequencing alone. Rapid genomic workflows require immediate sample logistics, continuous laboratory processing, accelerated bioinformatics, expert clinical interpretation and prompt medical reporting.
Building and maintaining this level of integration in-house is often impractical, particularly for hospitals or laboratories that only occasionally manage urgent genomic cases.
For these situations, Breda Genetics offers an accredited Exome Ultra-Fast workflow, delivering a clinical report within 5 working days (3 working days for the FASTQs) from DNA receipt, while preserving the same standards of quality, interpretation and diagnostic responsibility applied to every clinical case.
Clinical exome analysis with accredited reporting for rare disease diagnostics.
Comprehensive genomic analysis for complex and unresolved clinical cases.
Flexible, exome-based gene panels supported by continuously updated gene–disease knowledge.
Integrated rapid workflow with FASTQs in 3 working days and a clinical Medical Report in 5 working days.
Contact us for pricing, TAT and sample submission.
Contact us to identify the most appropriate diagnostic approach.